跳至主要内容
临床试验/CTRI/2022/07/043639
CTRI/2022/07/043639已完成2 期

Efficacy of Dashamoola Siddha Taila Matrabasti And Uttarbasti in the management of Mootraghata W.S.R. To Benign Prostatic Hyperplasia - An Open Labelled Randomized Comparative Clinical Trial

Government Akhandanand Ayurved College Ahmedabad0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients presenting with classical signs and symptoms of
  • Mootraghata/BPH like Incomplete emptying, Increased Frequency,
  • Intermittency, Urgency, Weak stream,Straining, Nocturia, Painful
  • mituration, Burning micturition
  • 2. Male patient Age between 40-80 year
  • 3. Controlled case of Diabetes mellitus (RBS upto 180 mg/dl) and
  • Hypertension (upto 150/90 mm Hg)

排除标准

  • 1. CA Prostate
  • 2. Urethral stricture
  • 3. Benign tumour of urethra
  • 4. Malignant tumour of urethra
  • 5. Urethral injury, urethral calculi
  • 6. Age above 80 years and below 40 years
  • 7. Patients with systemic diseases like uncontrolled Hypertension (more
  • than 150/90 mm Hg) and uncontrolled Diabetes mellitus (RBS more than
  • 180 mg/dl),Tuberculosis, VDRL, STD, HIV, HBsAg
  • 8. Known case of heart disease
  • 9. According Ayurveda point of view, Matrabasti should not be
  • administered in the persons having Ajirna and who has slept during

研究者

发起方
Government Akhandanand Ayurved College Ahmedabad

相似试验